|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
61,413,000 |
Market
Cap: |
9.16(B) |
Last
Volume: |
875,140 |
Avg
Vol: |
504,506 |
52
Week Range: |
$114.17 - $208.42 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Repligen is a life sciences company that develops and commercializes bioprocessing technologies and systems used in the process of manufacturing biological drugs. Co.'s bioprocessing business is comprised of:Filtration, which includes XCell Alternating Tangential Flow systems that are used in upstream perfusion cell culture processing; Chromatography, which includes products used in downstream purification, development, manufacturing and quality control of biological drugs; Process Analytics, which complements and supports its Filtration, Chromatography and Proteins franchises; and Proteins, which are represented by its Protein A affinity ligands and cell culture growth factor products.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
1,500 |
Total Buy Value |
$0 |
$0 |
$0 |
$238,260 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
3 |
Total Shares Sold |
40,296 |
45,669 |
50,307 |
151,828 |
Total Sell Value |
$7,357,263 |
$8,416,817 |
$9,119,818 |
$30,980,273 |
Total People Sold |
2 |
4 |
5 |
6 |
Total Sell Transactions |
3 |
5 |
7 |
17 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Cooper Glenn L Md |
Director |
|
2017-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,206 |
38,300 |
|
- |
|
Muir Glenn P |
Director |
|
2017-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,206 |
2,969 |
|
- |
|
Ryan Thomas F Jr |
Director |
|
2017-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,206 |
8,700 |
|
- |
|
Barthelemy Nicholas |
Director |
|
2017-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,206 |
3,988 |
|
- |
|
Hunt Anthony |
Chief Executive Officer |
|
2017-05-10 |
4 |
D |
$37.97 |
$86,393 |
D/D |
(2,275) |
92,583 |
|
- |
|
Ryan Thomas F Jr |
Director |
|
2017-03-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,100 |
7,494 |
|
- |
|
Dawes Karen A |
Director |
|
2017-03-21 |
4 |
S |
$34.12 |
$86,017 |
D/D |
(2,521) |
93,243 |
|
- |
|
Dawes Karen A |
Director |
|
2017-03-21 |
4 |
OE |
$4.29 |
$85,800 |
D/D |
20,000 |
95,764 |
|
- |
|
Benjamin Howard |
VP Business Development |
|
2017-03-20 |
4 |
OE |
$6.23 |
$141,341 |
D/D |
14,968 |
33,908 |
|
- |
|
Benjamin Howard |
VP Business Development |
|
2017-03-20 |
4 |
S |
$34.61 |
$422,954 |
D/D |
(12,216) |
23,908 |
|
- |
|
Ryan Thomas F Jr |
Director |
|
2017-03-20 |
4 |
S |
$34.83 |
$139,321 |
D/D |
(4,000) |
8,594 |
|
- |
|
Ryan Thomas F Jr |
Director |
|
2017-03-20 |
4 |
OE |
$3.22 |
$12,880 |
D/D |
4,000 |
12,594 |
|
- |
|
Snodgres Jon |
Chief Financial Officer |
|
2017-03-17 |
4 |
OE |
$24.50 |
$98,000 |
D/D |
4,000 |
27,789 |
|
- |
|
Snodgres Jon |
Chief Financial Officer |
|
2017-03-17 |
4 |
S |
$34.91 |
$66,646 |
D/D |
(1,909) |
23,789 |
|
- |
|
Benjamin Howard |
VP Business Development |
|
2017-03-01 |
4 |
D |
$32.08 |
$63,387 |
D/D |
(1,976) |
31,156 |
|
- |
|
Hunt Anthony |
Chief Executive Officer |
|
2017-03-01 |
4 |
D |
$32.07 |
$191,524 |
D/D |
(5,972) |
94,858 |
|
- |
|
Snodgres Jon |
Chief Financial Officer |
|
2017-03-01 |
4 |
D |
$32.07 |
$52,273 |
D/D |
(1,630) |
25,698 |
|
- |
|
Benjamin Howard |
VP Business Development |
|
2017-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
4,506 |
33,132 |
|
- |
|
Hunt Anthony |
Chief Executive Officer |
|
2017-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
32,488 |
100,830 |
|
- |
|
Snodgres Jon |
Chief Financial Officer |
|
2017-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
9,875 |
27,328 |
|
- |
|
Rusche James R |
SENIOR VICE PRESIDENT |
|
2016-12-23 |
5 |
GD |
$0.00 |
$0 |
D/D |
4,700 |
95,816 |
|
- |
|
Hunt Anthony |
Chief Executive Officer |
|
2016-11-28 |
4 |
AS |
$33.12 |
$165,613 |
D/D |
(5,000) |
68,342 |
|
- |
|
Ryan Thomas F Jr |
Director |
|
2016-09-14 |
4 |
S |
$32.58 |
$87,979 |
D/D |
(2,700) |
9,394 |
|
- |
|
Ryan Thomas F Jr |
Director |
|
2016-08-24 |
5 |
GD |
$0.00 |
$0 |
D/D |
800 |
8,594 |
|
- |
|
Dawes Karen A |
Director |
|
2016-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
75,764 |
|
- |
|
464 Records found
|
|
Page 15 of 19 |
|
|